Shin-Etsu Polymer (7970) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
20 Mar, 2026Executive summary
Net sales for the nine months ended December 31, 2025, rose 3.7% year-over-year to ¥86,568 million, with operating profit up 1.4% to ¥11,010 million and profit attributable to owners of parent up 12.0% to ¥8,210 million.
The global economy showed gradual recovery, though U.S. trade policy continued to impact prices and demand, especially in the automotive sector.
The company focused on boosting sales, streamlining operations, expanding capacity, and exploring new growth themes.
Financial highlights
Ordinary profit increased 6.7% year-over-year to ¥11,178 million.
Basic earnings per share rose to ¥102.10 from ¥90.89 year-over-year.
Comprehensive income declined 30.1% year-over-year to ¥6,479 million, mainly due to foreign currency translation losses.
Equity ratio improved to 82.0% from 80.2% at the previous fiscal year-end.
Outlook and guidance
Full-year forecast for fiscal year ending March 31, 2026, remains unchanged: net sales of ¥113,500 million (+2.6% YoY), operating profit of ¥13,900 million (+4.7% YoY), and profit attributable to owners of parent of ¥9,500 million (+0.7% YoY).
Annual dividend forecast raised to ¥60.00 per share.
Latest events from Shin-Etsu Polymer
- Precision molding and advanced materials drive global growth, led by innovation and sustainability.7970
Corporate presentation20 Mar 2026 - Operating profit rose 5.7% despite lower sales, with full-year guidance and dividends increased.7970
Q1 202520 Mar 2026 - Operating profit rose 17.7% on strong Precision Molding and semiconductor market recovery.7970
Q2 202520 Mar 2026 - Strong profit growth and robust segment performance support an optimistic full-year outlook.7970
Q3 202520 Mar 2026 - Operating profit rose 20.1% year-over-year, led by semiconductors; FY2026 outlook withheld.7970
Q4 202520 Mar 2026 - Strong profit growth and higher dividend forecast, led by semiconductor and medical demand.7970
Q1 202620 Mar 2026 - Profits rose on semiconductor strength, but comprehensive income fell on currency losses.7970
Q2 202620 Mar 2026